High-dose therapy followed by autologous hematopoietic stem cell transplantation (auto-HCT) has become the treatment of choice for patients with relapsed aggressive non-Hodgkin lymphoma (NHL).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback